Page 26 - Morphosys This News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Morphosys this. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Morphosys This Today - Breaking & Trending Today

MorphoSys AG Reports Outcome of Annual General Meeting 2022

PLANEGG/MUNICH, GERMANY / ACCESSWIRE / May 18, 2022 / MorphoSys AG (FSE:MOR); (NASDAQ:MOR) announced today that its shareholders approved all resolutions proposed by the Company's Management and Supervisory ....

United States , Wendy Johnson , Julia Neugebauer , Andrew Cheng , Myles Clouston , Marc Cluzel , Thomas Biegi , Kaitlyn Nealy , Jean Paul Kress , Pricewaterhousecoopers Gmbh Wirtschaftspr , Articles Of Association , Company Management , Exchange Commission , Restricted Stock Unit Program , Supervisory Boards , Annual General Meeting , Supervisory Board , Conditional Capital , Authorized Capital , Stock Unit Program , Remuneration Report , Management Board , Executive Committee , Chief Executive Officer , Morphosy Annual Report ,

MorphoSys Shareholders Approve All Resolutions Proposed By Its Boards

MARTINSRIED (dpa-AFX) - MorphoSys AG (MOR, MPSYY.PK) said that its shareholders approved all resolutions proposed by the company's Management and Supervisory Boards at the company's virtual Annual ....

Wendy Johnson , Pricewaterhousecoopers Gmbh Wirtschaftspr , Restricted Stock Unit Program , Articles Of Association , Supervisory Boards , Annual General , Annual General Meeting , Pricewaterhousecoopers Gmbh , Andrew Cheng , Supervisory Board , Conditional Capital , Authorized Capital , Restricted Stock Unit , United Statessubsidiaries , Restricted Stock Unit Program , Management Board , Remuneration Report ,

Chutes & Ladders—Merck loses another top exec, this time to Moderna

Welcome to this week's Chutes & Ladders, our ro ....

Chutes And Ladders , Ronny Gal , Bristol Myers Squibb , Nektar Therapeutics , Solid Biosciences , Caladrius Biosciences , Baxter International , Generate Biomedicines , Vedere Bio , Jnana Therapeutics , Y Mabs Therapeutics , Icahn School Of Medicine At Mount Sinai , Flare Therapeutics , Homology Medicines , Fierce Biotech Homepage ,

MorphoSys AG: Invitation to MorphoSys' First Quarter 2022 Financial Results Conference Call on May 5, 2022

PLANEGG/MUNICH, GERMANY / ACCESSWIRE / April 28, 2022 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) will publish its results for the first quarter 2022 on May 4, 2022 at 10:00 pm CEST (9:00 pm GMT; 4:00 pm EDT).MorphoSys' ....

United States , United Kingdom , Thomas Biegi , Julia Neugebauer , Myles Clouston , Jeanette Bressi , Exchange Commission , Us Communications , Morphosy Annual Report ,

MorphoSys AG (ETR:MOR) Receives Consensus Recommendation of "Buy" from Analysts

MorphoSys AG (ETR:MOR – Get Rating) has been given a consensus rating of “N/A” by the seven brokerages that are currently covering the company, Marketbeat Ratings reports. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is €55.14 ($59.94). MOR has been the topic […] ....

United States , Jpmorgan Chase Co , Berenberg Bank , Morphosys Company Profile Get Rating , Deutsche Bank Aktiengesellschaft , Get Rating , Marketbeat Ratings , Bank Aktiengesellschaft , Sys Company Profile , Petr Mor ,